Cholecystokinin protects mouse liver against ischemia and reperfusion injury
- 1 July 2017
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 48, 180-186
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81401577, 81201455)
This publication has 36 references indexed in Scilit:
- Cholecystokinin Plays a Novel Protective Role in Diabetic Kidney Through Anti-inflammatory Actions on MacrophageDiabetes, 2012
- Receptor activator of nuclear factor-κB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in miceHepatology, 2011
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology, 2011
- Diversity in post-transcriptional control of neutrophil chemoattractant cytokine gene expressionCytokine, 2010
- Liver ischemia/reperfusion injury: Processes in inflammatory networks—A reviewLiver Transplantation, 2010
- CXC chemokines play a critical role in liver injury, recovery, and regenerationThe American Journal of Surgery, 2009
- The relationship between gastric emptying, plasma cholecystokinin, and peptide YY in critically ill patientsCritical Care, 2007
- Cholecystokinin and Gastrin ReceptorsPhysiological Reviews, 2006
- Current progress in the understanding of and therapeutic strategies for ischemia and reperfusion injury of the liverJournal of Hepato-Biliary-Pancreatic Surgery, 2003
- Visualization of cholecystokinin receptors on a subset of human monocytes and in rat spleenPeptides, 1991